PULM Stock Analysis: Buy, Sell, or Hold?
PULM - Pulmatrix, Inc. Common Stock
$1.51
0.01 (0.67%)
▲
5d:
+1.34%
30d:
+12.69%
90d:
-29.77%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When PULM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PULM shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: PULM shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PULM is currently trading at $1.51, which is considered extended relative to its 30-day fair value range of $1.31 to $1.46.
Technical Outlook: Technically, PULM is in a strong downtrend. The price is approaching resistance at $1.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PULM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+566.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PULM is in a strong downtrend. The price is approaching resistance at $1.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PULM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+566.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.31 -
$1.46
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 566.7% below Wall St target ($10.00)
Trading Range Analysis
30-Day Trading Range
$1.31 -
$1.46
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.22
Resistance Level
$1.55
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$10.00
(+566.7%)
Revenue Growth (YoY)
-99.9%
Share & Embed Analysis
Last updated: June 24, 2026 10:30 AM ET
Data refreshes hourly during market hours. Next update: 11:30 AM
Data refreshes hourly during market hours. Next update: 11:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PULM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
